Jan 05, 2021 / 08:20PM GMT
Robert Patrick Jones - Goldman Sachs Group, Inc., Research Division - VP
Good afternoon, everyone, and welcome to the Humana session. I'm Bob Jones here at Goldman Sachs. I cover healthcare services and managed care. I'm very excited to have President and CEO, Bruce Broussard from Humana with us as well as Amy Smith, VP of Investor Relations. So a Happy New Year, and welcome to you both. We're going to obviously ask a series of questions here.
Questions and Answers:
Robert Patrick Jones - Goldman Sachs Group, Inc., Research Division - VPA lot of things are very topical. But I thought, Bruce, maybe just given how top of mind it is right now for everyone? Wanted to just start with the vaccine and the rollout specifically. I know it's very early days, but there's some debate on how the rollout has progressed. Just curious for Humana's perspective on how they've seen the vaccine rollout began. And then more specifically, are there specific things you managed doing to encourage members or educate members around getting back to date?
Bruce Dale